ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies

• Jonathan A Ledermann,
• Ilaria Betella,
• Maria Del Grande,
• Francesco Multinu,
• Cristiana Sessa,
• Ilaria Colombo,
• Eleonora Zaccarelli,
• Federica Tomao,
• Antonio Gonzalez-Martin

Affiliations

Jonathan A Ledermann

Department of Oncology and Cancer Trials, UCL Cancer Institute, London, UK

Ilaria Betella

Department of Gynecologic Oncology, European Institute of Oncology, Milano, Italy

Maria Del Grande

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Francesco Multinu

Department of Gynecologic Oncology, European Institute of Oncology, Milano, Italy

Cristiana Sessa

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Ilaria Colombo

Aff4 0000 0001 2157 2938grid.17063.33Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada

Eleonora Zaccarelli

Department of Gynecologic Oncology, European Institute of Oncology, Milano, Italy

Federica Tomao

Department of Gynecologic Oncology, European Institute of Oncology, Milano, Italy

Antonio Gonzalez-Martin

Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain